Table 6. Associations of EBBS-Barriers and EBBS-Benefits with the disease indices.
| r-axSpA (n=108) | nr-axSpA (n=40) | All axSpA (n=148) | |||||
| EBBS-Barriers | EBBS-Benefits | EBBS-Barriers | EBBS-Benefits | EBBS-Barriers | EBBS-Benefits | ||
| TSK* | r | -0.394 | -0.329 | -0.502 | -0.357 | -0.424 | -0.344 |
| p | <0.01 | <0.01 | <0.01 | 0.02 | <0.01 | <0.01 | |
| BASDAI | r | -0.175 | -0.001 | -0.172 | -0.295 | -0.176 | -0.065 |
| p | 0.07 | >0.99 | 0.29 | 0.07 | 0.03 | 0.43 | |
| BASFI | r | -0.105 | -0.126 | -0.148 | -0.258 | -0.123 | -0.162 |
| p | 0.29 | 0.20 | 0.36 | 0.11 | 0.14 | 0.05 | |
| BASMI | r | -0.185 | -0.208 | -0.121 | -0.141 | -0.198 | -0.221 |
| p | 0.06 | <0.01 | 0.46 | 0.39 | 0.02 | 0.01 | |
| ASQoL | r | -0.223 | -0.239 | -0.250 | -0.394 | -0.228 | -0.273 |
| p | 0.02 | 0.01 | 0.12 | 0.01 | <0.01 | <0.01 | |
| ASAS-HI | r | -0.251 | -0.258 | -0.282 | -0.412 | -0.255 | -0.291 |
| p | 0.01 | 0.01 | 0.08 | 0.01 | <0.01 | <0.01 | |
| HADS-anxiety | r | -0.187 | -0.257 | -0.290 | -0.267 | -0.201 | -0.249 |
| p | 0.05 | 0.01 | 0.07 | 0.10 | 0.01 | <0.01 | |
| HADS-depression | r | -0.165 | -0.285 | -0.123 | -0.237 | -0.154 | -0.271 |
| p | 0.09 | <0.01 | 0.45 | 0.14 | 0.06 | <0.01 | |
| EBBS: Exercise Benefits/Barriers scale; r-axSpA: Radiographic axial spondyloarthritis; nr-axSpA: Nonradiographic axial spondyloarthritis; axSpA: Axial spondyloarthritis; TSK: Tampa scale of kinesiophobia; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; BASFI: Bath Ankylosing Spondylitis Functional Index; BASMI: Bath Ankylosing Spondylitis Metrology Index; ASQoL: Ankylosing Spondylitis Quality of Life Questionnaire; ASAS-HI: The Assessment of SpondyloArthritis international Society Health Index; HADS: Hospital Anxiety and Depression Scale; r: Pearson correlation coefficient; Written in bold: p<0.05 and r>0.3. * The level of correlations between EBBS scores and TSK were calculated for convergent validity analysis. | |||||||